|
1
|
Schub D, Janssen E, Leyking S, Sester U,
Assmann G, Hennes P, Smola S, Vogt T, Rohrer T, Sester M and
Schmidt T: Altered phenotype and functionality of varicella zoster
virus-specific cellular immunity in individuals with active
infection. J Infect Dis. 211:600–612. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Kim YH, Hwang JY, Lee KM, Choi JH, Lee TY,
Choi JS and Park HS: Seroepidemiologic survey of varicella-zoster
virus in korean adults using glycoprotein enzyme immuno assay and
fluorescent antibody to membrane antigen test. Ann Dermatol.
23:39–43. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Suenaga T, Matsumoto M, Arisawa F, Kohyama
M, Hirayasu K, Mori Y and Arase H: Sialic acids on varicella-zoster
virus glycoprotein B are required for cell-cell fusion. J Biol
Chem. 290:19833–19843. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dendouga N, Fochesato M, Lockman L,
Mossman S and Giannini SL: Cell-mediated immune responses to a
varicella-zoster virus glycoprotein E vaccine using both a TLR
agonist and QS21 in mice. Vaccine. 30:3126–3135. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Grahn A, Studahl M, Nilsson S, Thomsson E,
Bäckström M and Bergström T: Varicella-zoster virus (VZV)
glycoprotein E is a serological antigen for detection of
intrathecal antibodies to VZV in central nervous system infections,
without cross-reaction to herpes simplex virus 1. Clin Vaccine
Immunol. 18:1336–1342. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Thomsson E, Persson L, Grahn A, Snäll J,
Ekblad M, Brunhage E, Svensson F, Jern C, Hansson GC, Bäckström M
and Bergström T: Recombinant glycoprotein E produced in mammalian
cells in large-scale as an antigen for varicella-zoster-virus
serology. J Virol Methods. 175:53–59. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Oliver SL, Sommer MH, Reichelt M, Rajamani
J, Vlaycheva-Beisheim L, Stamatis S, Cheng J, Jones C, Zehnder J
and Arvin AM: Mutagenesis of varicella-zoster virus glycoprotein I
(gI) identifies a cysteine residue critical for gE/gI heterodimer
formation, gI structure and virulence in skin cells. J Virol.
85:4095–4110. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Zerboni L, Berarducci B, Rajamani J, Jones
CD, Zehnder JL and Arvin A: Varicella-zoster virus glycoprotein E
is a critical determinant of virulence in the SCID mouse-human
model of neuropathogenesis. J Virol. 85:98–111. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Permyakova NV, Zagorskaya AA, Belavin PA,
Uvarova EA, Nosareva OV, Nesterov AE, Novikovskaya AA, Zav'yalov
EL, Moshkin MP and Deineko EV: Transgenic carrot expressing fusion
protein comprising M. tuberculosis antigens induces immune
response in mice. Biomed Res Int. 2015:4175652015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Berarducci B, Rajamani J, Zerboni L, Che
X, Sommer M and Arvin AM: Functions of the unique N-terminal region
of glycoprotein E in the pathogenesis of varicella-zoster virus
infection. Proc Natl Acad Sci USA. 107:282–287. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Ali MA, Li Q, Fischer ER and Cohen JI: The
insulin degrading enzyme binding domain of varicella-zoster virus
(VZV) glycoprotein E is important for cell-to-cell spread and VZV
infectivity, while a glycoprotein I binding domain is essential for
infection. Virology. 386:270–279. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sauerbrei A, Wiesener N, Zell R and
Wutzler P: Sequence analysis of the glycoprotein E gene of
varicella-zoster virus strains of clades 1, 3 and 5. Arch Virol.
156:505–509. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Wang M, Tang JW, Song B, Wang B, Zhang J,
Wei YY, Zhang YH and Liu JW: Construction and identification of
recombinant eukaryotic plasmid pcDNA3.1(+)-ECH1. Zhong Hua Bing Li
Xue Za Zhi. 40:334–335. 2011.(In Chinese).
|
|
14
|
Zhang Y, Chang S, Sun J, Zhu S, Pu C, Li
Y, Zhu Y, Wang Z and Xu RX: Targeted microbubbles for ultrasound
mediated short hairpin RNA plasmid transfection to inhibit survivin
gene expression and induce apoptosis of ovarian cancer A2780/DDP
Cells. Mol Pharm. 12:3137–3145. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Liu JC, Lengner CJ, Gaur T, Lou Y, Hussain
S, Jones MD, Borodic B, Colby JL, Steinman HA, van Wijnen AJ, et
al: Runx2 protein expression utilizes the Runx2 P1 promoter to
establish osteoprogenitor cell number for normal bone formation. J
Biol Chem. 286:30057–30070. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Laderman EI, Whitworth E, Dumaual E, Jones
M, Hudak A, Hogrefe W, Carney J and Groen J: Rapid, sensitive and
specific lateral-flow immunochromatographic point-of-care device
for detection of herpes simplex virus type 2-specific
immunoglobulin G antibodies in serum and whole blood. Clin Vaccine
Immunol. 15:159–163. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Shipkova M and Wieland E: Surface markers
of lymphocyte activation and markers of cell proliferation. Clin
Chim Acta. 413:1338–1349. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Im EJ, Borducchi EN, Provine NM, McNally
AG, Li S, Frankel FR and Barouch DH: An attenuated Listeria
monocytogenes vector primes more potent simian immunodeficiency
virus-specific mucosal immunity than DNA vaccines in mice. J Virol.
87:4751–4755. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Chesnut G, McClain D and Galeckas K:
Varicella-zoster virus in children immunized with the varicella
vaccine. Cutis. 90:114–116. 2012.PubMed/NCBI
|
|
20
|
Ghanem A, Healey R and Adly FG: Current
trends in separation of plasmid DNA vaccines: A review. Anal Chim
Acta. 760:1–15. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Storlie J, Maresova L, Jackson W and Grose
C: Comparative analyses of the 9 glycoprotein genes found in
wild-type and vaccine strains of varicella-zoster virus. J Infect
Dis. 197(Suppl 2): S49–S53. 2008. View
Article : Google Scholar : PubMed/NCBI
|
|
22
|
Berarducci B, Rajamani J, Reichelt M,
Sommer M, Zerboni L and Arvin AM: Deletion of the first
cysteine-rich region of the varicella-zoster virus glycoprotein E
ectodomain abolishes the gE and gI interaction and differentially
affects cell-cell spread and viral entry. J Virol. 83:228–240.
2009. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Polack FP, Lydy SL, Lee SH, Rota PA,
Bellini WJ, Adams RJ, Robinson HL and Griffin DE: Poor immune
responses of newborn rhesus macaques to measles virus DNA vaccines
expressing the hemagglutinin and fusion glycoproteins. Clin Vaccine
Immunol. 20:205–210. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Meng M, He S, Zhao G, Bai Y, Zhou H, Cong
H, Lu G, Zhao Q and Zhu XQ: Evaluation of protective immune
responses induced by DNA vaccines encoding Toxoplasma gondii
surface antigen 1 (SAG1) and 14–3-3 protein in BALB/c mice. Parasit
Vectors. 5:2732012. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Galli V, Simionatto S, Marchioro SB, Fisch
A, Gomes CK, Conceição FR and Dellagostin OA: Immunisation of mice
with Mycoplasma hyopneumoniae antigens P37, P42, P46 and P95
delivered as recombinant subunit or DNA vaccines. Vaccine.
31:135–140. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Herrada AA, Rojas-Colonelli N,
González-Figueroa P, Roco J, Oyarce C, Ligtenberg MA and Lladser A:
Harnessing DNA-induced immune responses for improving cancer
vaccines. Hum Vaccin Immunother. 8:1682–1693. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Fredriksen AB, Sandlie I and Bogen B:
Targeted DNA vaccines for enhanced induction of idiotype-specific B
and T cells. Front Oncol. 2:1542012. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Yu YZ, Li N, Ma Y, Wang S, Yu WY and Sun
ZW: Three types of human CpG motifs differentially modulate and
augment immunogenicity of nonviral and viral replicon DNA vaccines
as built-in adjuvants. Eur J Immunol. 43:228–239. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Martinez-Lopez A, Encinas P,
García-Valtanen P, Gomez-Casado E, Coll JM and Estepa A: Improving
the safety of viral DNA vaccines: Development of vectors containing
both 5′ and 3′ homologous regulatory sequences from non-viral
origin. Appl Microbiol Biotechnol. 97:3007–3016. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Cai MS, Deng SX and Li ML: Comparison of
the immune responses in BALB/c mice following immunization with
DNA-based and live attenuated vaccines delivered via different
routes. Vaccine. 31:1353–1356. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Li L, Saade F and Petrovsky N: The future
of human DNA vaccines. J Biotechnol. 162:171–182. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Hartikka J, Bozoukova V, Morrow J, Rusalov
D, Shlapobersky M, Wei Q, Boutsaboualoy S, Ye M, Wloch MK, Doukas
J, et al: Preclinical evaluation of the immunogenicity and safety
of plasmid DNA-based prophylactic vaccines for human
cytomegalovirus. Hum Vaccin Immunother. 8:1595–1606. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Zhang M, Hu YH, Xiao ZZ, Sun Y and Sun L:
Construction and analysis of experimental DNA vaccines against
megalocytivirus. Fish Shellfish Immunol. 33:1192–1198. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Jiang DB, Sun YJ, Cheng LF, Zhang GF, Dong
C, Jin BQ, Song CJ, Ma Y, Zhang FL and Yang K: Construction and
evaluation of DNA vaccine encoding Hantavirus glycoprotein
N-terminal fused with lysosome-associated membrane protein.
Vaccine. 33:3367–3376. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
35
|
Zhai Y, Zhou Y, Li X and Feng G:
Immune-enhancing effect of nano-DNA vaccine encoding a gene of the
prME protein of Japanese encephalitis virus and BALB/c mouse
granulocyte-macrophage colony-stimulating factor. Mol Med Rep.
12:199–209. 2015.PubMed/NCBI
|
|
36
|
Malavige GN, Jones L, Black AP and Ogg GS:
Varicella zoster virus glycoprotein E-specific CD4+ T cells show
evidence of recent activation and effector differentiation,
consistent with frequent exposure to replicative cycle antigens in
healthy immune donors. Clin Exp Immunol. 152:522–531. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
Schmidt-Chanasit J, Bleymehl K, Schäd SG,
Gross G, Ulrich RG and Doerr HW: Novel varicella-zoster virus
glycoprotein E gene mutations associated with genotypes A and D. J
Clin Microbiol. 46:325–327. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Connolly RJ, Chapman T, Hoff AM, Kutzler
MA, Jaroszeski MJ and Ugen KE: Non-contact helium-based plasma for
delivery of DNA vaccines: Enhancement of humoral and cellular
immune responses. Hum Vaccin Immunother. 8:1729–1733. 2012.
View Article : Google Scholar : PubMed/NCBI
|
